Analysis of the microcrystalline inclusion compounds of triclosan with β-cyclodextrin and its tris-O-methylated derivative

Journal of Pharmaceutical and Biomedical Analysis

Volumn 80, Issue , 2013, Pages 34-43

  Ramos, Ana I ^a   Braga, Teresa M ^b   Fernandes, José A ^a   Silva, Patrícia ^a   Ribeiro Claro, Paulo J ^a   Almeida Paz, Filipe A ^a   de Fátima Silva Lopes, Maria ^b,c   Braga, Susana S ^a,d  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^c INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA   (Portugal)

^d UNIVERSITY OF AVEIRO   (Portugal)

Author keywords

CD; Antimicrobial activity; Environmental bacteria; Inclusion compounds; TRIMEB

Indexed keywords

BETA CYCLODEXTRIN; TRICLOSAN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS; BACTERIAL GROWTH; BACTERIUM ISOLATION; CALCULATION; CARBON NUCLEAR MAGNETIC RESONANCE; CRYSTAL; CRYSTALLIZATION; DRUG SYNTHESIS; ENTEROCOCCUS; ESCHERICHIA; EVAPORATION; GEOMETRY; GROWTH INHIBITION; INFRARED SPECTROSCOPY; LISTERIA; METHYLATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SALMONELLA; STAPHYLOCOCCUS; THERMOGRAVIMETRY; X RAY DIFFRACTION;

ANTI-INFECTIVE AGENTS, LOCAL; BETA-CYCLODEXTRINS; CRYSTALLIZATION; CYCLODEXTRINS; DRUG CARRIERS; DRUG COMPOUNDING; ENVIRONMENTAL MICROBIOLOGY; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THERMOGRAVIMETRY; TRICLOSAN; X-RAY DIFFRACTION;

EID: 84875583314     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2013.02.033     Document Type: Article

References (59)

1. Bhargava H.N., Leonard P.A. Triclosan: applications and safety. Am. J. Infect. Control 1996, 24:209-218.
2. Russell A.D. Whither triclosan?. J. Antimicrob. Chemother. 2004, 53:693-695.
3. Heath R.J., Li J., Roland G.E., Rock C.O. Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene. J. Biol. Chem. 2000, 275:4654-4659.
4. McMurry L.M., Oethinger M., Levy S.B. Triclosan targets lipid synthesis. Nature 1998, 394:531-532.
5. Jones R.D., Jampani H.B., Newman J.L., Lee A.S. Triclosan: a review of effectiveness and safety in health care settings. Am. J. Infect. Control 2000, 28:184-196.
6. Campbell L., Zirwas M.J. Product allergen watch: triclosan. Dermatitis 2006, 17:204-207.
7. Surolia N., Surolia A. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nat. Med. 2001, 7:167-173.
8. Sharma S.K., Parasuraman P., Kumar G., Surolia N., Surolia A. Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR). J. Med. Chem. 2007, 50:765-775.
9. Heath R.J., Rock C.O. A triclosan-resistant bacterial enzyme. Nature 2000, 406:145-146.
10. Buth J.M., Steen P.O., Sueper C., Blumentritt D., Vikesland P.J., Arnold W.A., McNeill K. Dioxin photoproducts of triclosan and its chlorinated derivatives in sediment cores. Environ. Sci. Technol. 2010, 44:4545-4551.
11. Zorrilla L.M., Gibson E.K., Jeffay S.C., Crofton K.M., Setzer W.R., Cooper R.L., Stoker T.E. The effects of triclosan on puberty and thyroid hormones in male Wistar rats. Toxicol. Sci. 2008, 107:56-64.
12. Allmyr M., Adolfsson-Erici M., McLachlan M.S., Sandborgh-Englund G. Triclosan in plasma and milk from Swedish nursing mothers and their exposure via personal care products. Sci. Total Environ. 2006, 372:87-93.
13. Loftsson T., Ossurardottir I.B., Duan M., Zhao N., Thorsteinsson T., Masson M. Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: effect of ionization and polymers. J. Incl. Phenom. Macro 2005, 52:109-117.
14. Grove C., Liebenberg W., Prez J.L., Yang W., Villiers M.M. Improving the aqueous solubility of triclosan by solubilization, complexation and in situ salt formation. J. Cosmet. Sci. 2003, 54:537-550.
15. Yeguas V., López R., Lambert A., Monard G., Ruiz-López M.F. Computer simulation of reactions in β-cyclodextrin molecular reactors: transition state recognition. Org. Biomol. Chem. 2010, 8:4346-4355.
16. Braga S.S. Modern alchemy with metal complexes inside cyclodextrins, the molecular cauldrons. Curr. Org. Chem. 2010, 14:1356-1361.
17. Szejtli J. Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 1998, 98:1743-1753.
18. Saenger W. Cyclodextrin inclusion-compounds in research and industry. Angew. Chem. Int. Ed. Engl. 1980, 19:344-362.
19. Braga S.S., Gonçalves I.S., Herdtweck E., Teixeira-Dias J.J.C. Solid state inclusion compound of S-ibuprofen in β-cyclodextrin: structure and characterization. New J. Chem. 2003, 27:597-601.
20. Braga S.S., Ribeiro-Claro P., Pillinger M., Gonçalves I.S., Pereira F., Fernandes A.C., Romão C.C., Correia P.B., Teixeira-Dias J.J.C. Encapsulation of sodium nimesulide and precursors in β-cyclodextrin. Org. Biomol. Chem. 2003, 1:873-878.
21. Braga S.S., Ribeiro-Claro P., Pillinger M., Gonçalves I.S., Fernandes A.C., Pereira F., Romão C.C., Correia P.B., Teixeira-Dias J.J.C. Interactions of omeprazole and precursors with beta-cyclodextrin host molecules. J. Incl. Phenom. Macro. 2003, 47:47-52.
22. 2 MoCl2) with beta-cyclodextrin. J. Organomet. Chem. 2001, 632:11-16.
23. 2) in 2-hydroxypropyl- and trimethyl-beta-cyclodextrin: structural and biological properties. J. Organomet. Chem. 2005, 690:2905-2912.
24. Pereira C.C.L., Nolasco M., Braga S.S., Paz F.A.A., Ribeiro-Claro P., Pillinger M., Gonçalves I.S. A combined theoretical-experimental study of the inclusion of niobocene dichloride in native and permethylated beta-cyclodextrins. Organometallics 2007, 26:4220-4228.
25. Loftsson T., Leeves N., Bjornsdottir B., Duffy L., Masson M. Effect of cyclodextrin and polymers on triclosan availability and substantivity in toothpastes in vivo. J. Pharm. Sci. 1999, 88:1254-1258.
26. Lu J., Hill M.A., Hood M., Greeson D.F., Horton J.R., Ordnoff P.E., Herndon A.S., Tonelli A.E. Formation of antibiotic, biodegradable polymers by processing with Irgasan DP300 R (Triclosan) and its inclusion compound with β-cyclodextrin. J. Appl. Polym. Sci. 2001, 82:300-309.
27. Jug M., Kosalec I., Maestrelli F., Mura P. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative. J. Pharm. Biomed. Anal. 2011, 54:1030-1039.
28. Veiga M.D., Merino M., Cirri M., Maestrelli F., Mura P. Comparative study on triclosan interactions in solution and in the solid state with natural and chemically modified cyclodextrins. J. Incl. Phenom. Macro. 2005, 53:77-83.
29. Celebioglu A., Uyar T. Electrospinning of polymer-free nanofibers from cyclodextrin inclusion complexes. Langmuir 2011, 27:6218-6226.
30. Paulidou A., Maffeo D., Yannakopoulou K., Mavridis I.M. Crystal structure of the inclusion complex of the antibacterial agent triclosan with cyclomaltoheptaose and NMR study of its molecular encapsulation in positively and negatively charged cyclomaltoheptaose derivatives. Carbohydr. Res. 2008, 343:2634-2640.
31. Dinge A., Nagarsenker M. Formulation and evaluation of fast dissolving films for delivery of triclosan to the oral cavity. AAPS PharmSciTech 2008, 9:349-356.
32. Kottke T., Stalke D. Crystal handling at low-temperatures. J. Appl. Crystallogr. 1993, 26:615-619.
33. APEX2, Data Collection Software, Version 2.1-RC13, Bruker AXS, Delft, The Netherlands, 2006.
34. Cryopad, Remote monitoring and control, Version 1.451, Oxford Cryosystems, Oxford, United Kingdom, 2006.
35. SAINT+, Data Integration Engine, Version 7.23a ©, Bruker AXS, Madison, WI, USA, 1997-2005.
36. G.M. Sheldrick, SADABS, Version 2.01, Bruker/Siemens Area Detector Absorption Correction Program, Bruker AXS, Madison, WI, USA, 1998.
37. G.M. Sheldrick, SHELXS-97, program for crystal structure solution, University of Göttingen, 1997.
38. Sheldrick G.M. A short history of SHELX. Acta Crystallogr. A 2008, 64:112-122.
39. G.M. Sheldrick, SHELXL-97, program for crystal structure refinement, University of Göttingen, 1997.
40. Spek A.L. PLATON, an integrated tool for the analysis of the results of a single crystal structure determination. Acta Crystallogr. A 1990, 46:C34.
41. Spek A.L. Single-crystal structure validation with the program PLATON. J. Appl. Crystallogr. 2003, 36:7-13.
42. van der Sluis P., Spek A.L. BYPASS - an effective method for the refinement of crystal-structures containing disordered solvent regions. Acta Crystallogr. A 1990, 46:194-201.
43. Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Montgomery J.A., Vreven T., Kudin K.N., Burant J.C., Millam J.M., Iyengar S.S., Tomasi J., Barone V., Mennucci B., Cossi M., Scalmani G., Rega N., Petersson G.A., Nakatsuju H., Hada M., Ehara M., Toyota K., Fukuda R., Hasegawa J., Ishida M., Nakajima T., Honda Y., Kitao O., Nakai H., Klene M., Li X., Knox J.E., Hratchian H.P., Cross J.B., Adamo C., Jaramillo J., Gomperts R., Stratmann R.E., Yazyev O., Austin A.J., Cammi R., Pomelli C., Ochterski J., Ayala P.Y., Morokuma K., Voth G.A., Salvador P., Dannenberg J.J., Zakrzewski V.G., Dapprich S., Daniels A.D., Strain M.C., Farkas J., Malick A.D., Rabuck A.D., Raghavachari K., Foresman J.B., Ortiz J.V., Cui Q., Baboul A.G., Clifford S., Cioslowski J., Stefanov B.B., Liu G., Liashenko A., Piskorz P., Komaromi I., Martin D.J., Fox D.J., Keith T., Al-Laham M.A., Peng C.Y., Nanayakkara A., Challacombe M., Gill B.G., Johnson B.G., Chen W., Wong M.W., Gonzalez C., Pople J.A. Gaussian 03 2003, Gaussian Inc., Pittsburgh, PA.
44. Ramos A.I., Braga S.S., Paz F.A.A. Triclosan. Acta Crystallogr. C 2009, 65:o404-o405.
45. Allen F.H. The Cambridge Structural Database: a quarter of a million crystal structures and rising. Acta Crystallogr. B 2002, 58:380-388.
46. Allen F.H., Motherwell W.D.S. Applications of the Cambridge Structural Database in organic chemistry and crystal chemistry. Acta Crystallogr. B 2002, 58:407-422.
47. National Committee for Clinical Laboratory Standards, Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically, sixth edition, Approved Standard M7-A6, NCCLS, Wayne, PA, USA, 2003.
48. Marques J., Braga T.M., Paz F.A.A., Santos T.M., Lopes M.F.S., Braga S.S. Cyclodextrins improve the antimicrobial activity of the chloride salt of Ruthenium(II) chloro-phenanthrolinetrithiacyclononane. Biometals 2009, 22:541-556.
49. Trotta F., Zanetti M., Camino G. Thermal degradation of cyclodextrins. Polym. Degrad. Stabil. 2000, 69:373-379.
50. Ramos A.I., Braga T.M., Silva P., Fernandes J.A., Ribeiro-Claro P., Lopes M.F.S., Paz F.A.A., Braga S.S. CrystEngComm 2013, 15:2822-2834.
51. Caira M.R. On the isostructurality of cyclodextrin inclusion complexes and its practical utility. Rev. Roum. Chim. 2001, 46:371-386.
52. Bruno S.M., Fernandes J.A., Marques J., Neto S.C., Ribeiro-Claro P.J., Pillinger M., Paz F.A.A., Marques M.P.M., Braga S.S., Gonçalves I.S. Structural studies and cytotoxicity of trimethyl(ferrocenylmethyl)ammonium iodide encapsulated in beta-cyclodextrin. Eur. J. Inorg. Chem. 2011, 4955-4963.
53. Casadesus R., Moreno M., Gonzalez-Lafont A., Lluch J.M., Repasky M.P. Testing electronic structure methods for describing intermolecular H center dot center dot center dot H interactions in supramolecular chemistry. J. Comput. Chem. 2004, 25:99-105.
54. Braga S.S., Paz F.A.A., Pillinger M., Seixas J.D., Romão C.C., Gonçalves I.S. Structural studies of β-cyclodextrin and permethylated β-cyclodextrin inclusion compounds of cyclopentadienyl metal carbonyl complexes. Eur. J. Inorg. Chem. 2006, 1662-1669.
55. Heyes S.J., Clayden N.J., Dobson C.M. C-13-CP/MAS NMR-studies of the cyclomalto-oligosaccharide (cyclodextrin) hydrates. Carbohydr. Res. 1992, 233:1-14.
56. Gidley M.J., Bociek S.M. C-13 CP/MAS NMR-studies of amylose inclusion complexes, cyclodextrins, and the amorphous phase of starch granules - relationships between glycosidic linkage conformation and solid-state C-13 chemical-shifts. J. Amer. Chem. Soc. 1988, 110:3820-3829.
57. Veregin R.P., Fyfe C.A., Marchessault R.H., Taylor M.G. Correlation of C-13 chemical-shifts with torsional angles from high-resolution, C-13 CP-MAS NMR-studies of crystalline cyclomalto-oligosaccharide complexes, and their relation to the structures of the starch polymorphs. Carbohydr. Res. 1987, 160:41-56.
58. Caira M.R., Bourne S.A., Mhlongo W.T., Dean P.M. New crystalline forms of permethylated beta-cyclodextrin. Chem. Commun. 2004, 2216-2217.
59. Guillén J., Bernabeu A., Shapiro S., Villalaín J. Location and orientation of Triclosan in phospholipid model membranes. Eur. Biophys. J. 2004, 33:448-453.